These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33708259)

  • 1. Kushenin Combined with Adefovir Dipivoxil or Entecavir for Chronic Hepatitis B: A Systematic Review and Meta-Analysis.
    Liao Q; Wen J; Jiang K; Zhao Y; Ma X
    Evid Based Complement Alternat Med; 2021; 2021():8856319. PubMed ID: 33708259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kushenin Combined with Nucleos(t)ide Analogues for Chronic Hepatitis B: A Systematic Review and Meta-Analysis.
    Chen Z; Ma X; Zhao Y; Wang J; Zhang Y; Zhu Y; Wang L; Chen C; Wei S; Yang Z; Gong M; Shen H; Bai Z; Guo Y; Niu M; Xiao X
    Evid Based Complement Alternat Med; 2015; 2015():529636. PubMed ID: 26347789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of telbivudine plus adefovir dipivoxil combination therapy and entecavir monotherapy for HBeAg-positive chronic hepatitis B patients with resistance to adefovir dipivoxil.
    Lu JJ; Liu K; Ma YJ; Wang J; Chen EQ; Tang H
    J Viral Hepat; 2013 Apr; 20 Suppl 1():40-5. PubMed ID: 23458523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compare with safety and efficacy of entecavir and adefovir dipivoxil combination therapy and tenofovir disoproxil fumarate monotherapy for chronic hepatitis B patient with adefovir-resistant.
    Lai MC; Lian JS; Zhang WJ; Xu J; Zhou L; Zheng SS
    Math Biosci Eng; 2019 Oct; 17(1):627-635. PubMed ID: 31731368
    [No Abstract]   [Full Text] [Related]  

  • 6. Optimized combination therapies with adefovir dipivoxil (ADV) and lamivudine, telbivudine, or entecavir may be effective for chronic hepatitis B patients with a suboptimal response to ADV monotherapy.
    Li X; Jie Y; You X; Shi H; Zhang M; Wu Y; Lin G; Li X; Gao Z; Chong Y
    Int J Clin Exp Med; 2015; 8(11):21062-70. PubMed ID: 26885037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing the efficacy and safety of tenofovir and adefovir or combined drug treatment for the treatment of chronic hepatitis B infection: a systematic review and meta-analysis.
    Bi Z; Wang L; Hou H; Lu M; Wang W; Li Z; Liu C
    Ann Transl Med; 2022 Sep; 10(18):1016. PubMed ID: 36267714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Entecavir 1.0mg monotherapy or entecavir plus adefovir dipivoxil for patients with lamivudine-resistant chronic hepatitis B had suboptimal response to lamivudine plus adefovir dipivoxil].
    Xing J; Han T; Liu L; Li Y; Li J; Li Y; Xiao SX
    Zhonghua Gan Zang Bing Za Zhi; 2011 Nov; 19(11):828-32. PubMed ID: 22433304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy and safety of Entecavir monotherapy switched from Lamivudine combined Adefovir Dipivoxil for chronic hepatitis B virus-related compensated liver cirrhosis].
    Lai XJ; Lian JS; Chen JY; Zhang YM; Jia HY; Zheng L; Yang YD
    Zhonghua Gan Zang Bing Za Zhi; 2018 Feb; 26(2):113-118. PubMed ID: 29804377
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the antiviral effects of entecavir and adefovir dipivoxil in chronic HBV infection: a randomized control trial.
    Jiang YF; He B; Ma J; Li NP; Gong GZ; Cheng D
    Acta Gastroenterol Belg; 2012 Sep; 75(3):316-21. PubMed ID: 23082701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of 2years of entecavir plus adefovir therapy in patients with chronic hepatitis B who had failed on prior nucleos(t)ide analog treatment.
    Wang X; Zhang C; Zhu Y; Xiong Y; Wang Y
    Antiviral Res; 2014 Mar; 103():71-7. PubMed ID: 24462954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of lamivudine combined with adefovir dipivoxil versus entecavir monotherapy in patients with hepatitis B-associated decompensated cirrhosis: A meta-analysis.
    Peng H; Liu J; Yang M; Tong S; Yin W; Tang H; Hu P; Hu H; Ren H
    J Clin Pharmacol; 2014 Feb; 54(2):189-200. PubMed ID: 24105676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing Efficacy of Lamivudine, Adefovir Dipivoxil, Telbivudine, and Entecavir in Treating Nucleoside Analogues Naïve for HBeAg-Negative Hepatitis B with Medium Hepatitis B Virus (HBV) DNA Levels.
    Shi H; Han Z; Liu J; Xue J; Zhang S; Zhu Z; Xia J; Huang M
    Med Sci Monit; 2017 Nov; 23():5230-5236. PubMed ID: 29095799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and safety of lamivudine plus adefovir combination therapy and entecavir monotherapy for chronic hepatitis B patients].
    Yu JH; Shi JP; Wu J; Li XO; Guo JC; Xun YH; Zhao C; Jin J; Xu AF; Lou GQ
    Zhonghua Gan Zang Bing Za Zhi; 2011 Feb; 19(2):88-92. PubMed ID: 21492508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of entecavir and adefovir for the treatment of chronic hepatitis B.
    Zhao SH; Liu EQ; Cheng DX; Li YF; Wang YL; Chen YL; Sun WT; Yan XC; Dang SS
    Braz J Infect Dis; 2012; 16(4):366-72. PubMed ID: 22846126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of three adefovir-based combination therapies in HBeAg-positive chronic hepatitis B patients with suboptimal response to adefovir monotherapy.
    Wang ML; Chen EQ; Zhang DM; Du LY; Yan LB; Zhou TY; Lei XZ; Lei BJ; Lu JJ; Liao J; Tang H
    J Viral Hepat; 2017 Nov; 24 Suppl 1():21-28. PubMed ID: 29082645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kushenin combined with entecavir for chronic hepatitis B: A protocol for a systematic review and meta-analysis.
    Wang Y; Zhang J; Jin Y; Xiao X; Zhang Q
    Medicine (Baltimore); 2020 Jan; 99(5):e18898. PubMed ID: 32000393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monotherapy with tenofovir disoproxil fumarate for adefovir-resistant vs. entecavir-resistant chronic hepatitis B: A 5-year clinical trial.
    Lim YS; Gwak GY; Choi J; Lee YS; Byun KS; Kim YJ; Yoo BC; Kwon SY; Lee HC
    J Hepatol; 2019 Jul; 71(1):35-44. PubMed ID: 30876946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Three year adefovir dipivoxil treatment for hepatitis B e antigen-positive chronic hepatitis B patients].
    Ling N; Zhou Z; Zhang DZ; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2007 May; 15(5):346-9. PubMed ID: 17524266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the 48-week efficacy of Lamivudine plus Adefovir or Entecavir monotherapy in patients with HBeAg negative hepatitis following Lamivudine treatment failure.
    Zhang Q; Zhang L; Xing Y; Qin Y; Liu G
    Acta Gastroenterol Belg; 2019; 82(1):31-34. PubMed ID: 30888751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.